Sibar Auto Parts (520141)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹12.8 |
| Market Cap | ₹21.15 Cr |
| P/E Ratio | 0 |
| ROCE | 0.69% |
| ROE | -7.31% |
| Dividend Yield | 0% |
| Profit Growth | -228.57% |
| Debt/Equity | — |
| Sales Growth | 11.65% |
| 52-Week Range | ₹6.5 — ₹12.8 |
| Sector | Auto Components |
| Book Value | ₹5.7 |
Strengths
- Sales growth of 11.65% indicates some business momentum despite losses.
- Tangible book value of ₹5.70 per share provides an asset cushion.
- ROCE of 0.69% is positive, suggesting operations are not completely value-destructive.
- Small market cap of ₹21 Cr leaves potential for meaningful growth if turnaround succeeds.
Concerns
- Negative ROE of -7.31% implies shareholder value is being destroyed.
- Profit growth of -228.57% and latest quarterly net profit of ~₹0 Cr show no earnings to support the valuation.
- P/B of 2.25 is expensive for a company with negative returns on equity.
- Piotroski F-Score of 4/9 and undisclosed debt/equity raise financial health and capital structure uncertainties.
AI Analysis
As a value investor, I look for businesses that convert growth into owner earnings. Sibar Auto Parts shows top-line growth of 11.65%, but the bottom line tells a troubling story. Profit growth is -228.57%, and the latest quarter's net profit is effectively nil, leading to a P/E of 0.00. The company earns a negative return on equity of -7.31%, meaning every rupee of retained capital is being eroded. Book value stands at ₹5.70, yet the market prices it at ₹12.80, or 2.25 times book. In Graham's framework, paying a premium to book for a business that cannot earn its cost of capital is unsafe. The positive ROCE of 0.69% offers faint hope, but it is far below any risk-free rate. The Piotroski F-Score of 4/9 reinforces my caution—this is not a financially robust enterprise. There is no dividend to reward shareholders while we wait. Being a small auto-component supplier in a cyclical industry, the company could be a turnaround play if management controls costs and margins recover. However, I need evidence, not promises. I would monitor whether the 11.65% sales growth eventually flows through to profits, whether ROE turns positive, and how capital is being financed. Debt/Equity is not disclosed, which is a red flag in itself. At ₹12.80, the market is pricing in a revival that has not yet appeared in the financials. As Mr. Buffett says, 'It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price.' Sibar at 2.25 times book with negative returns is neither wonderful nor fair. I would keep it on the watchlist, but not in the portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer